In NSCLC patients, intra-tumoral IL-37 expression is significantly suppressed at both the mRNA and protein levels (16 ... of various pro-inflammatory cytokines, including IL-6, CCL5, and CXCL10, which ...

MRNA technology is facing growing doubts among Republicans. This is a KFF Health News story. Researchers racing to develop bird flu vaccines for humans have turned to a cutting-edge technology ...

Vaccine skeptics have long-since leveraged the rapid roll out of mRNA vaccines to add fuel to heated arguments surrounding vaccine safety. As a result, a growing share of the public is wary of ...

A bill to make it a crime to administer mRNA vaccines in Iowa — like the Moderna and Pfizer COVID shots — has cleared initial review in the Iowa Senate. However, the bill’s sponsor plans to ...

In this article, we are going to look at where Moderna, Inc. (NASDAQ:MRNA) stands against other biotech stocks. Biotech Sector Set for Growth Amid Innovation and Investor Interest The ...

Yet vaccines using the new technology of mRNA were developed by Moderna and Pfizer/BioNTech in a matter of months, and were already being put into arms by the first anniversary of the pandemic.

This was in addition to the $176 million awarded by the US Department of Health and Human Services (HHS) last year to complete the late-stage development and testing of a pre-pandemic mRNA-based ...

Vaccine manufacturers would have to waive indemnity from lawsuits for injuries stemming from vaccines under a bill advancing in the Iowa Senate. Sen. Doug Campbell, R-Mason City, at a subcommittee ...

CureVac and partner GSK are, meanwhile, also developing an mRNA-based flu vaccine, but are a little further back in development, as their shot is in phase 1 testing.

GSK has upgraded its longstanding alliance with CureVac on mRNA-based vaccines for respiratory infections, paying €400 million ($429 million) upfront for global rights to its influenza and COVID ...